SelectHealth has been recently recognized as an NCQA Partner in QualityJune 26, 2020
Selecthealth Medical Home is an NCQA Partner in Quality -- a program that recognizes organizations providing financial incentives or support services for NCQA - recognized practices. Learn more.
2021 Changes in Varicose Vein Procedure AuthorizationsJune 09, 2020
Effective January 1, 2021, authorized varicose vein procedures (commercial and Medicare Advantage plans) must be done in a facility with Intersocietal Accreditation Commission (IAC) accreditation as a vein center. Learn more.
Medical Oncology: New Preauthorization Services from AIM Specialty HealthMay 14, 2020
Effective June 1, 2020, SelectHealth will partner with AIM Specialty Health (AIM) to manage clinical appropriateness and preauthorization review for intravenous and injectable medical oncology services for members on all plans. Learn more.
Genetic Testing and Radiation Oncology Services: Changes to Clinical Appropriateness and Preauthorization ReviewsSeptember 12, 2019
Effective October 1, 2019, AIM Specialty Health®(AIM) will manage genetic testing and radiation oncology clinical appropriateness and preauthorization review for all SelectHealth members on commercial, Medicare, Medicaid, and Children’s Health Insurance Program (CHIP). Learn how to get started with AIM.